🇺🇸 FDA
Pipeline program

CellCept 500 mg film-coated tablets, CellCept 1 g/5 ml powder for oral suspension, Gazyvaro 1,000 mg concentrate for solution for infusion., CellCept 500 mg film-coated tablets

WA43380

Phase 3 small_molecule active

Quick answer

CellCept 500 mg film-coated tablets, CellCept 1 g/5 ml powder for oral suspension, Gazyvaro 1,000 mg concentrate for solution for infusion., CellCept 500 mg film-coated tablets for Childhood Idiopathic Nephrotic Syndrome is a Phase 3 program (small_molecule) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Roche Registration Limited
Indication
Childhood Idiopathic Nephrotic Syndrome
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials